Transcription of Disclaimer for Compliance with USP an Assessment …
{{id}} {{{paragraph}}}
Example: stock market
Disclaimer for Compliance with USP an Assessment …
Practical Strategies for Compliance with USP <800>: Performing an Assessment of Risk 21th Annual ASHP Conference for Pharmacy Leaders Disclaimer Patricia Kienle is a member of the USP Compounding Expert Committee, but this presentation is not endorsed by or affiliated with USP. Practical Strategies for Compliance with USP <800>: Performing an Assessment of Risk Patricia C. Kienle, RPh, MPA, FASHP. Director, Accreditation and Medication Safety Cardinal Health Innovative Delivery Solutions Laflin, Pennsylvania Objectives Preparation Cite the document that defines hazardous drugs Read Assessment of Risk section from USP <800>.
Your Hazardous Drug List 1. Review the NIOSH list of hazardous drugs 2. Identify the drugs and dosage forms you handle 3. Perform an Assessment of Risk
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Of Antineoplastic and Other Hazardous, Of Antineoplastic and Other Hazardous Drugs, Centers for Disease Control and Prevention, NIOSH List of Antineoplastic and Other Hazardous, NIOSH List of Antineoplastic and Other, ASHP Guidelines on Handling Hazardous Drugs, Hazardous drugs ASHP Guidelines on Handling Hazardous Drugs, Hazardous drugs, USP <800> CSTD, Health impacts of health-care waste, Other, Hazardous